Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstone Exploration Regulatory News (TXP)

Share Price Information for Touchstone Exploration (TXP)

Share Price is delayed by 15 minutes
Get Live Data
7.00    -0.25 (-3.45%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £22.73m
TXP Live PriceLast checked at - London Stock Exchange

Intraday Touchstone Exploration Share Chart

Form 8.5 (EPT/RI)

3 Jul 2024 07:28

RNS Number : 9504U
Canaccord Genuity Limited
03 July 2024
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Touchstone Exploration Inc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeror

 

(d) Date dealing undertaken:

02 July 2024

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

Com NPV (DI)

 

 

 

 

Sales

 

 

36,210

 

 

29.85p

 

 

29.85p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

Date of disclosure:

3 July 2024

Contact name:

David Baker

Telephone number:

020 7523 4656

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERZZGGNVFNGDZG
Date   Source Headline
6th Jul 20237:14 amRNSShare Purchase Plan
30th Jun 20237:00 amRNSRESULTS OF 2023 SHAREHOLDERS' MEETING
29th Jun 20237:00 amRNSOPERATIONAL UPDATE & INVESTOR PRESENTATION
20th Jun 20237:47 amRNSSale of Common Shares and PDMR Shareholding
14th Jun 20237:00 amRNSEXERCISE OF SHARE OPTIONS
13th Jun 20237:26 amRNS2022 Trinidad Onshore Bid Round Results
12th Jun 20237:00 amRNSSHARE OPTIONS AND DIRECTOR / PDMR SHAREHOLDING
7th Jun 20232:42 pmRNSEXERCISE OF SHARE OPTIONS
6th Jun 20237:00 amRNSShare Purchase Plan
26th May 20237:00 amRNSUS$7 MILLION REVOLVING LOAN FACILITY
17th May 20234:41 pmRNSSETTLEMENT AGREEMENT
12th May 20237:00 amRNSQ1 2023 FINANCIAL AND OPERATING RESULTS
2nd May 20237:00 amRNSSHARE PURCHASE PLAN
24th Apr 20237:00 amRNSRESULTS OF INITIAL ROYSTON-1X PRODUCTION TEST
5th Apr 20237:00 amRNSSHARE PURCHASE PLAN
24th Mar 20237:00 amRNSFull Year 2022 Results
23rd Mar 20237:00 amRNSAIM Rule 17 Schedule 2(g) Update
6th Mar 20237:00 amRNS2022 Year-End Reserves
2nd Mar 20237:00 amRNSROYSTON-1X REACHES TOTAL DEPTH
1st Mar 20236:23 pmRNSEMPLOYEE SHARE PURCHASE PLAN
27th Feb 20237:00 amRNSCASCADURA FACILITY UPDATE
6th Feb 20237:00 amRNSCOMMENCEMENT OF ROYSTON-1X OPERATIONS
1st Feb 20234:52 pmRNSEmployee Share Purchase Plan
9th Jan 20237:00 amRNSExecution of Asset Exchange Agreement
6th Jan 20237:30 amRNSShare Purchase Plan and Director/PDMR Purchases
28th Dec 20221:30 pmRNSRelease of 2021 Sustainability Report
12th Dec 202212:13 pmEQSTouchstone Exploration to restart drilling after raising $13mln
6th Dec 20224:40 pmRNSTOUCHSTONE RAISES APPROXIMATELY US$13 MILLION
6th Dec 20227:00 amRNSCANADIAN PRIVATE PLACEMENT & PROPOSED UK PLACING
1st Dec 20227:00 amRNSEMPLOYEE SHARE PURCHASE PLAN
10th Nov 20227:00 amRNSTHIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
1st Nov 20227:00 amRNSSHARE PURCHASE PLAN AND DIRECTOR / PDMR PURCHASES
11th Oct 20227:00 amRNSFIRST NATURAL GAS PRODUCTION FROM COHO
3rd Oct 20227:10 amRNSDIRECTOR / PDMR PURCHASES
9th Sep 202211:03 amRNSEXERCISE OF SHARE OPTIONS
2nd Sep 20227:00 amRNSSHARE PURCHASE PLAN AND DIRECTOR / PDMR PURCHASES
1st Sep 20227:45 amRNSDIRECTOR / PDMR SHAREHOLDING
30th Aug 20228:56 amRNSGRANT OF SHARE OPTIONS
26th Aug 202210:59 amRNSDIRECTOR / PDMR SHAREHOLDING
22nd Aug 20227:00 amRNSEXERCISE OF SHARE OPTIONS
17th Aug 20229:05 amRNSSecond Price Monitoring Extn
17th Aug 20229:00 amRNSPrice Monitoring Extension
17th Aug 20227:00 amRNSAPPROVAL OF CASCADURA CEC
11th Aug 20227:00 amRNSQ2 2022 FINANCIAL AND OPERATING RESULTS
8th Aug 20224:40 pmRNSSecond Price Monitoring Extn
8th Aug 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20222:05 pmRNSSecond Price Monitoring Extn
8th Aug 20222:00 pmRNSPrice Monitoring Extension
8th Aug 202211:05 amRNSSecond Price Monitoring Extn
8th Aug 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.